Radionuclide skeletal survey in neuroblastoma

Area of Science:

• Nuclear Medicine
• Pediatric Oncology
• Radiology

Background:

• Neuroblastoma is a common childhood cancer originating from neural crest cells.
• Accurate staging of neuroblastoma, including bone involvement, is crucial for treatment planning and prognosis.

Purpose of the Study:

• To evaluate the diagnostic accuracy of 99mTc-phosphate bone imaging in patients with neuroblastoma.
• To compare bone imaging with skeletal radiography for detecting metastatic disease.

Main Methods:

• Retrospective analysis of 63 bone scintigraphy studies in 49 patients with confirmed neuroblastoma.
• Review of 42 skeletal radiographic surveys for comparison.
• Assessment of tracer uptake patterns, including primary tumor and metastatic lesions.

Main Results:

• 41 of 63 bone images were abnormal, revealing skeletal metastatic disease in 29 patients.
• Primary tumor tracer uptake was observed in 17 patients, considered pathognomonic for neural crest neoplasms.
• Bone imaging demonstrated higher accuracy than radiography in detecting bone involvement.

Conclusions:

• 99mTc-phosphate bone imaging is a highly sensitive tool for detecting skeletal metastases in neuroblastoma.
• Primary tumor uptake on bone scintigraphy is a strong indicator of neural crest origin.
• Radionuclide bone imaging offers superior diagnostic value compared to skeletal radiography for neuroblastoma staging.